Português
Português English Español 日本

Webinar

Watch the Recording

Objective, functional testing for glaucoma?
Yes, and done in minutes!

Justin Schweitzer OD, FAAO

Presented By:
Justin Schweitzer, OD, FAAO
"When it comes to accurate glaucoma testing, perimetry is only half the picture. Functional diagnostics are vital."

About the presenter

About the Webinar

Objective glaucoma testing is here — And it's far easier than you think

Testing for glaucoma can be tricky. Accurate diagnosis is key. but that’s easier said than done! Perimetry is subjective, while imaging can often be inconclusive or obscured by media opacities. The newly enhanced PhNR test on the RETeval® dispositivo aids in the accurate detection and tracking of glaucoma by testing retinal ganglion health at the functional level.

In this webinar, I’m going to present the latest diagnostic tools and strategies to provide the most accurate and predictive patient information. I’ll be focusing on the portable and non-invasive RETeval Device. This technology has made objective and functional retina ganglion cell testing both practical and straightforward.

Talk to us about putting the RETeval device into your clinic

About

Justin Schweitzer, OD, FAAO

Dr. Justin Schweitzer specializes in advanced glaucoma, refractive surgical clinical care, and anterior segment pathology at Vance Thompson Vision. He received his professional training and Doctor of Optometry degree from Pacific University College of Optometry in Forest Grove, OR.

In 2012, he pursued his dream to focus on glaucoma, advanced anterior segment surgery care and pathology, joining Vance Thompson Vision in Sioux Falls, South Dakota. He earned Fellowship in the American Academy of Optometry in 2013, is the Optometric Externship Director at Vance Thompson Vision, and Adjunct Clinical Professor of the Illinois College of Optometry and Kentucky College of Optometry.

Dr. Schweitzer regularly lectures on glaucoma, anterior segment pathology, refractive surgical clinical care, and surgical management at state, regional, and national meetings. He is currently the Chief Medical Editor for Modern Optometry and has contributed book chapters, journal articles, and case studies in peer reviewed and non-peer reviewed journals including Review of Optometry, Optometry Times, Primary Care Optometry News, Optometric Management, The Journal of Cataract and Refractive Surgery, Clinical Ophthalmology, and The Journal of Glaucoma. He has research interests in minimally invasive glaucoma surgery and biomechanical properties of the cornea as it relates to glaucoma.

Dr. Schweitzer is an advocate of an integrated eye care delivery model and is currently serving as a board member for the South Dakota Optometric Society. He also serves as a board member of the Optometric Glaucoma Society, a member of the American Optometric Association; Optometric Cornea, Cataract, and Refractive Society; Scleral Lens Education Society; Intrepid Eye Society; and is actively involved in his community’s eye care initiatives.

Learn more about the RETeval dispositivo
Justin Schweitzer OD, FAAO
cropped-cropped-LKC_logo_RGB_color_no_tagline_mini_400px.png
© 2024 LKC Technologies, Inc.

About Dr. Schweitzer OD, FAAO

Justin Schweitzer OD, FAAO

Dr. Justin Schweitzer specializes in advanced glaucoma, refractive surgical clinical care, and anterior segment pathology at Vance Thompson Vision. He received his professional training and Doctor of Optometry degree from Pacific University College of Optometry in Forest Grove, OR.

In 2012, he pursued his dream to focus on glaucoma, advanced anterior segment surgery care and pathology, joining Vance Thompson Vision in Sioux Falls, South Dakota. He earned Fellowship in the American Academy of Optometry in 2013, is the Optometric Externship Director at Vance Thompson Vision, and Adjunct Clinical Professor of the Illinois College of Optometry and Kentucky College of Optometry.

An Adjunct Clinical Professor at the Illinois College of Optometry, Dr. Schweitzer regularly lectures on glaucoma, anterior segment pathology, refractive surgical clinical care, and surgical management at state, regional, and national meetings. He is currently the Chief Medical Editor for Modern Optometry and has contributed book chapters, journal articles, and case studies in peer-reviewed and non-peer-reviewed journals including Review of Optometry, Optometry Times, Primary Care Optometry News, Optometric Management, The Journal of Cataract and Refractive Surgery, Clinical Ophthalmology, and The Journal of Glaucoma. He has research interests in minimally invasive glaucoma surgery and biomechanical properties of the cornea as it relates to glaucoma.

Dr. Schweitzer is an advocate of an integrated eye care delivery model and is currently serving as a board member for the South Dakota Optometric Society. He also serves as a board member of the Optometric Glaucoma Society, a member of the American Optometric Association; Optometric Cornea, Cataract, and Refractive Society; Scleral Lens Education Society; Intrepid Eye Society; and is actively involved in his community’s eye care initiatives.

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity